P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment

Gliomas are the most common malignant brain tumors in adults, characterized by a high proliferation and invasion. The tumor microenvironment is rich in growth-promoting signals and immunomodulatory pathways, which increase the tumor’s aggressiveness. In response to hypoxia and glioma therapy, the am...

Full description

Bibliographic Details
Main Authors: Fernanda Bueno Morrone, Pedro Vargas, Liliana Rockenbach, Thamiris Becker Scheffel
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/20/6146
_version_ 1797513703718912000
author Fernanda Bueno Morrone
Pedro Vargas
Liliana Rockenbach
Thamiris Becker Scheffel
author_facet Fernanda Bueno Morrone
Pedro Vargas
Liliana Rockenbach
Thamiris Becker Scheffel
author_sort Fernanda Bueno Morrone
collection DOAJ
description Gliomas are the most common malignant brain tumors in adults, characterized by a high proliferation and invasion. The tumor microenvironment is rich in growth-promoting signals and immunomodulatory pathways, which increase the tumor’s aggressiveness. In response to hypoxia and glioma therapy, the amounts of adenosine triphosphate (ATP) and adenosine diphosphate (ADP) strongly increase in the extracellular space, and the purinergic signaling is triggered by nucleotides’ interaction in P2 receptors. Several cell types are present in the tumor microenvironment and can facilitate tumor growth. In fact, tumor cells can activate platelets by the ADP-P2Y<sub>12</sub> engagement, which plays an essential role in the cancer context, protecting tumors from the immune attack and providing molecules that contribute to the growth and maintenance of a rich environment to sustain the protumor cycle. Besides platelets, the P2Y<sub>12</sub> receptor is expressed by some tumors, such as renal carcinoma, colon carcinoma, and gliomas, being related to tumor progression. In this context, this review aims to depict the glioma microenvironment, focusing on the relationship between platelets and tumor malignancy.
first_indexed 2024-03-10T06:21:17Z
format Article
id doaj.art-9f798d62b3cf422a8047a5fadc2dfe97
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T06:21:17Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-9f798d62b3cf422a8047a5fadc2dfe972023-11-22T19:18:45ZengMDPI AGMolecules1420-30492021-10-012620614610.3390/molecules26206146P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma MicroenvironmentFernanda Bueno Morrone0Pedro Vargas1Liliana Rockenbach2Thamiris Becker Scheffel3Laboratório de Farmacologia Aplicada, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre 90610-001, RS, BrazilLaboratório de Farmacologia Aplicada, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre 90610-001, RS, BrazilLaboratório de Farmacologia Aplicada, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre 90610-001, RS, BrazilLaboratório de Farmacologia Aplicada, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre 90610-001, RS, BrazilGliomas are the most common malignant brain tumors in adults, characterized by a high proliferation and invasion. The tumor microenvironment is rich in growth-promoting signals and immunomodulatory pathways, which increase the tumor’s aggressiveness. In response to hypoxia and glioma therapy, the amounts of adenosine triphosphate (ATP) and adenosine diphosphate (ADP) strongly increase in the extracellular space, and the purinergic signaling is triggered by nucleotides’ interaction in P2 receptors. Several cell types are present in the tumor microenvironment and can facilitate tumor growth. In fact, tumor cells can activate platelets by the ADP-P2Y<sub>12</sub> engagement, which plays an essential role in the cancer context, protecting tumors from the immune attack and providing molecules that contribute to the growth and maintenance of a rich environment to sustain the protumor cycle. Besides platelets, the P2Y<sub>12</sub> receptor is expressed by some tumors, such as renal carcinoma, colon carcinoma, and gliomas, being related to tumor progression. In this context, this review aims to depict the glioma microenvironment, focusing on the relationship between platelets and tumor malignancy.https://www.mdpi.com/1420-3049/26/20/6146purinergic signalingP2Y<sub>12</sub>gliomatumor microenvironmentplatelets
spellingShingle Fernanda Bueno Morrone
Pedro Vargas
Liliana Rockenbach
Thamiris Becker Scheffel
P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
Molecules
purinergic signaling
P2Y<sub>12</sub>
glioma
tumor microenvironment
platelets
title P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
title_full P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
title_fullStr P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
title_full_unstemmed P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
title_short P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
title_sort p2y sub 12 sub purinergic receptor and brain tumors implications on glioma microenvironment
topic purinergic signaling
P2Y<sub>12</sub>
glioma
tumor microenvironment
platelets
url https://www.mdpi.com/1420-3049/26/20/6146
work_keys_str_mv AT fernandabuenomorrone p2ysub12subpurinergicreceptorandbraintumorsimplicationsongliomamicroenvironment
AT pedrovargas p2ysub12subpurinergicreceptorandbraintumorsimplicationsongliomamicroenvironment
AT lilianarockenbach p2ysub12subpurinergicreceptorandbraintumorsimplicationsongliomamicroenvironment
AT thamirisbeckerscheffel p2ysub12subpurinergicreceptorandbraintumorsimplicationsongliomamicroenvironment